The global Rare Disease Drugs Market is experiencing remarkable growth as healthcare systems, pharmaceutical companies, and regulatory agencies increasingly focus on addressing unmet medical needs. Rare diseases, often referred to as orphan diseases, affect a relatively small percentage of the population. However, collectively they impact millions of people worldwide. The growing...

The rare disease drugs market is experiencing remarkable growth driven by innovations in gene therapies, RNA-based drugs, biologics, and precision medicine. In 2025, the global rare disease market size is estimated to be around $242.5 billion to $244.6 billion and is expected to nearly double or more, reaching between $374 billion and over $495 billion by the early 2030s, with a...